Literature DB >> 15257248

Fatty liver: how frequent is it and why?

Giorgio Bedogni1, Stefano Bellentani.   

Abstract

There is increasing evidence that fatty liver may be the most frequent liver disorder in Western countries. However, the epidemiology of fatty liver is still not fully understood and there is a clear need of better assessing and defining the potential role of the risk factors identified by clinical series in the general population. This article reviews the available data on the epidemiology of fatty liver and addresses some important questions that should be answered in much needed future research.

Entities:  

Mesh:

Year:  2004        PMID: 15257248

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  31 in total

1.  The prevalence and adverse profiles of fatty liver disease among different ethnic public servants in Urumqi of Xinjiang Uygur Autonomous Region in China.

Authors:  Dan Chen; Jie Guan; Xiang Xie; Wei-Yun Zhao; Palida Abulaiti; Yu Wang; Zhi-Qin Cheng; Jing Zhang; Ying Gao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Epidemiology of fatty liver: an update.

Authors:  Giorgio Bedogni; Valerio Nobili; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.

Authors:  G Misciagna; M Del Pilar Díaz; D V Caramia; C Bonfiglio; I Franco; M R Noviello; M Chiloiro; D I Abbrescia; A Mirizzi; M Tanzi; M G Caruso; M Correale; R Reddavide; R Inguaggiato; A M Cisternino; A R Osella
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Two-staged surgery for metastatic liver tumor in morbidly obese individual-left hemihepatectomy following placement of laparoscopic adjustable gastric band.

Authors:  Dariusz Szymanski; Adam Durczynski; Janusz Strzelczyk
Journal:  Obes Surg       Date:  2010-02-24       Impact factor: 4.129

Review 5.  Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

Authors:  Shira Zelber-Sagi; Vlad Ratziu; Ran Oren
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

6.  Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Authors:  Shira Zelber-Sagi; Muriel Webb; Nimer Assy; Laurie Blendis; Hanny Yeshua; Moshe Leshno; Vlad Ratziu; Zamir Halpern; Ran Oren; Erwin Santo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome.

Authors:  Dal-Sik Kim; Young-Kon Kim; Do-Sung Kim; Han-Jung Chae; Tae-Sun Park; Young I Cho; Seul-Ki Jeong
Journal:  Diabetol Metab Syndr       Date:  2010-03-22       Impact factor: 3.320

8.  A simple index of lipid overaccumulation is a good marker of liver steatosis.

Authors:  Giorgio Bedogni; Henry S Kahn; Stefano Bellentani; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2010-08-25       Impact factor: 3.067

Review 9.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

10.  Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.

Authors:  Rohan C Siriwardana; See Ching Chan; Kenneth S H Chok; Chung Mau Lo; Sheung Tat Fan
Journal:  HPB (Oxford)       Date:  2012-05-29       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.